AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Nita, ME Ono-Nita, SK Tsuno, N Tominaga, O Takenoue, T Sunami, E Kitayama, J Nakamura, Y Nagawa, H
Citation: Me. Nita et al., Bcl-X-L antisense sensitizes human colon cancer cell line to 5-fluorouracil, JPN J CANC, 91(8), 2000, pp. 825-832

Authors: Kato, N Yoshida, H Ono-Nita, SK Kato, J Goto, T Otsuka, M Lan, KH Matsushima, K Shiratori, Y Omata, M
Citation: N. Kato et al., Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer, HEPATOLOGY, 32(2), 2000, pp. 405-412

Authors: Yoshida, H Kato, H Shiratori, Y Lan, KH Ono-Nita, SK Feng, Z Shiina, S Omata, M
Citation: H. Yoshida et al., Poor association of TT virus viremia with hepatocellular carcinoma, LIVER, 20(3), 2000, pp. 247-252

Authors: Goto, T Kato, N Ono-Nita, SK Yoshida, H Otsuka, M Shiratori, Y Omata, M
Citation: T. Goto et al., Large isoform of hepatitis delta antigen activates serum response factor-associated transcription, J BIOL CHEM, 275(48), 2000, pp. 37311-37316

Authors: Ono-Nita, SK Kato, N Shiratori, Y Masaki, T Lan, KH Carrilho, FJ Omata, M
Citation: Sk. Ono-nita et al., YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection, HEPATOLOGY, 29(3), 1999, pp. 939-945

Authors: Ono-Nita, SK Kato, N Shiratori, Y Lan, KH Yoshida, H Carrilho, FJ Omata, M
Citation: Sk. Ono-nita et al., Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors, J CLIN INV, 103(12), 1999, pp. 1635-1640

Authors: Kato, N Lan, KH Ono-Nita, SK Yoshida, H Shiratori, Y Omata, M
Citation: N. Kato et al., Hepatitis C virus non-structural region 5A protein is a potent transcriptional activator, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 255-262

Authors: Ono-Nita, SK Kato, N Shiratori, Y Lan, KH Yoshida, H Carrilho, FJ Omata, M
Citation: Sk. Ono-nita et al., Influence of reverse transcriptase YMDD motif variants on replication and lamivudine resistance of hepatitis B virus, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 329-333
Risultati: 1-8 |